Cas:694-32-6 1-Methyl-2-imidazolidinone manufacturer & supplier

We serve Chemical Name:1-Methyl-2-imidazolidinone CAS:694-32-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Methyl-2-imidazolidinone

Chemical Name:1-Methyl-2-imidazolidinone
CAS.NO:694-32-6
Synonyms:MFCD00800601;1-Methyl-2-imidazolidinone;1-methylimidazolidin-2-one;2-Imidazolidinone, 1-methyl-
Molecular Formula:C4H8N2O
Molecular Weight:100.119
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:289.8±7.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.467
PSA:32.34000
Exact Mass:100.063660
LogP:-0.42

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD00800601 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Imidazolidinone, 1-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-methylimidazolidin-2-one Use and application,2-Imidazolidinone, 1-methyl- technical grade,usp/ep/jp grade.


Related News: As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 1-Methyl-2-imidazolidinone manufacturer As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 1-Methyl-2-imidazolidinone supplier Fears over the continuing spread of coronavirus have also fueled resentment and discrimination. Some have become outcasts in their own country, shunned by hotels, neighbors and — in some areas — placed under controversial quarantine measures. 1-Methyl-2-imidazolidinone vendor As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 1-Methyl-2-imidazolidinone factory As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment.